Published in Allergy on August 17, 2010
A single subset of dendritic cells controls the cytokine bias of natural killer T cell responses to diverse glycolipid antigens. Immunity (2014) 2.02
Treatment of allergic asthma: modulation of Th2 cells and their responses. Respir Res (2011) 1.31
Blockade of the B7-H1/PD-1 pathway for cancer immunotherapy. Yale J Biol Med (2011) 1.23
Programmed cell death ligand 2 regulates TH9 differentiation and induction of chronic airway hyperreactivity. J Allergy Clin Immunol (2012) 1.17
Label-free quantification and shotgun analysis of complex proteomes by one-dimensional SDS-PAGE/NanoLC-MS: evaluation for the large scale analysis of inflammatory human endothelial cells. Mol Cell Proteomics (2012) 1.14
RGMb is a novel binding partner for PD-L2 and its engagement with PD-L2 promotes respiratory tolerance. J Exp Med (2014) 1.09
Multiple mechanisms of immune suppression by B lymphocytes. Mol Med (2012) 1.08
Enhanced upper genital tract pathologies by blocking Tim-3 and PD-L1 signaling pathways in mice intravaginally infected with Chlamydia muridarum. BMC Infect Dis (2011) 0.90
Gene set signature of reversal reaction type I in leprosy patients. PLoS Genet (2013) 0.88
Intrahepatic expression of programmed death-1 and its ligands in patients with HBV-related acute-on-chronic liver failure. Inflammation (2013) 0.87
Biliary obstruction results in PD-1-dependent liver T cell dysfunction and acute inflammation mediated by Th17 cells and neutrophils. J Leukoc Biol (2013) 0.85
Control of pathogenic effector T-cell activities in situ by PD-L1 expression on respiratory inflammatory dendritic cells during respiratory syncytial virus infection. Mucosal Immunol (2014) 0.84
Clinical view on the importance of dendritic cells in asthma. Expert Rev Clin Immunol (2013) 0.84
Immune targeting of PD-1(hi) expressing cells during and after antiretroviral therapy in SIV-infected rhesus macaques. Virology (2013) 0.83
Expression of programmed death-1 (PD-1) on CD4+ and CD8+ T cells in rheumatoid arthritis. Inflammation (2014) 0.82
L2pB1: a new player in autoimmunity. Mol Immunol (2010) 0.79
B cells with regulatory properties in transplantation tolerance. World J Transplant (2015) 0.78
Searching for distinct mechanisms in eosinophilic and noneosinophilic airway inflammation. Am J Respir Crit Care Med (2014) 0.78
Lack of PD-L1 expression by iNKT cells improves the course of influenza A infection. PLoS One (2013) 0.76
Possible Noninvasive Biomarker of Eosinophilic Esophagitis: Clinical and Experimental Evidence. Case Rep Gastroenterol (2016) 0.75
Circulating T lymphocyte subsets, cytokines, and immune checkpoint inhibitors in patients with bipolar II or major depression: a preliminary study. Sci Rep (2017) 0.75
Pulmonary Delivery of Virosome-Bound Antigen Enhances Antigen-Specific CD4(+) T Cell Proliferation Compared to Liposome-Bound or Soluble Antigen. Front Immunol (2017) 0.75
Blomia tropicalis allergen 5 (Blo t 5) T-cell epitopes and their ability to suppress the allergic immune response. Immunology (2017) 0.75
Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med (2002) 23.42
PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature (2006) 20.00
Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med (2000) 19.81
PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol (2008) 19.24
B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat Med (1999) 16.91
Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade. Proc Natl Acad Sci U S A (2002) 12.39
Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity (1999) 12.36
PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat Immunol (2001) 12.26
Mouse and human dendritic cell subtypes. Nat Rev Immunol (2002) 10.01
Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. Immunity (2007) 8.94
Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J (1992) 8.86
Asthma. N Engl J Med (2001) 8.73
B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells. J Exp Med (2001) 6.97
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J Exp Med (2009) 6.80
The NOD mouse: a model of immune dysregulation. Annu Rev Immunol (2005) 6.71
Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat Med (2003) 6.42
PD-1 and PD-1 ligands: from discovery to clinical application. Int Immunol (2007) 6.24
Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production. J Immunol (2003) 6.07
Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. J Exp Med (2003) 6.06
Expression of programmed death 1 ligands by murine T cells and APC. J Immunol (2002) 5.78
PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion. J Virol (2006) 5.46
Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target. Proc Natl Acad Sci U S A (2004) 5.13
Dendritic cell regulation of TH1-TH2 development. Nat Immunol (2000) 5.13
Co-stimulatory members of the TNFR family: keys to effective T-cell immunity? Nat Rev Immunol (2003) 5.01
B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression. Clin Cancer Res (2004) 4.65
B7-H1 determines accumulation and deletion of intrahepatic CD8(+) T lymphocytes. Immunity (2004) 4.60
SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation. J Immunol (2004) 4.58
The development of allergic inflammation. Nature (2008) 4.52
Clinical significance and therapeutic potential of the programmed death-1 ligand/programmed death-1 pathway in human pancreatic cancer. Clin Cancer Res (2007) 4.41
Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection. J Virol (2007) 4.40
The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice. J Exp Med (2003) 4.20
Reinvigorating exhausted HIV-specific T cells via PD-1-PD-1 ligand blockade. J Exp Med (2006) 4.17
Asthma: an epidemic of dysregulated immunity. Nat Immunol (2002) 4.00
B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma. Cancer Res (2003) 3.96
PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2. Eur J Immunol (2002) 3.78
PD-1 is expressed by tumor-infiltrating immune cells and is associated with poor outcome for patients with renal cell carcinoma. Clin Cancer Res (2007) 3.23
PD-1 inhibits antiviral immunity at the effector phase in the liver. J Exp Med (2003) 3.05
PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells. Proc Natl Acad Sci U S A (2003) 3.02
Endothelial expression of PD-L1 and PD-L2 down-regulates CD8+ T cell activation and cytolysis. Eur J Immunol (2003) 2.91
The common gamma-chain cytokines IL-2, IL-7, IL-15, and IL-21 induce the expression of programmed death-1 and its ligands. J Immunol (2008) 2.85
Is the prevalence of asthma declining? Systematic review of epidemiological studies. Allergy (2009) 2.81
Programmed death 1 ligand signaling regulates the generation of adaptive Foxp3+CD4+ regulatory T cells. Proc Natl Acad Sci U S A (2008) 2.73
Establishment of NOD-Pdcd1-/- mice as an efficient animal model of type I diabetes. Proc Natl Acad Sci U S A (2005) 2.49
Induction of T helper type 1-like regulatory cells that express Foxp3 and protect against airway hyper-reactivity. Nat Immunol (2004) 2.43
Elevated expression levels of inhibitory receptor programmed death 1 on simian immunodeficiency virus-specific CD8 T cells during chronic infection but not after vaccination. J Virol (2007) 2.21
PD-L1 (B7-H1) expression by urothelial carcinoma of the bladder and BCG-induced granulomata: associations with localized stage progression. Cancer (2007) 2.00
Regulatory T cells in asthma. Immunity (2009) 2.00
B7DC/PDL2 promotes tumor immunity by a PD-1-independent mechanism. J Exp Med (2003) 1.92
Cooperative B7-1/2 (CD80/CD86) and B7-DC costimulation of CD4+ T cells independent of the PD-1 receptor. J Exp Med (2003) 1.85
Overexpression of B7-H1 (PD-L1) significantly associates with tumor grade and postoperative prognosis in human urothelial cancers. Cancer Immunol Immunother (2006) 1.81
PD-1 ligands, negative regulators for activation of naive, memory, and recently activated human CD4+ T cells. Cell Immunol (2004) 1.78
Thyroid allograft immunogenicity is reduced after a period in organ culture. Science (1975) 1.77
Airway hyperresponsiveness in asthma: not just a matter of airway inflammation. Thorax (1998) 1.72
Retracted Cross-linking the B7 family molecule B7-DC directly activates immune functions of dendritic cells. J Exp Med (2002) 1.68
Tregs and allergic disease. J Clin Invest (2004) 1.64
Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo. J Immunol (2005) 1.62
Murine vascular endothelium activates and induces the generation of allogeneic CD4+25+Foxp3+ regulatory T cells. J Immunol (2005) 1.61
B7-DC regulates asthmatic response by an IFN-gamma-dependent mechanism. J Immunol (2004) 1.61
PD-1/PD-L blockade prevents anergy induction and enhances the anti-tumor activities of glycolipid-activated invariant NKT cells. J Immunol (2009) 1.56
PD-L1 and PD-L2 modulate airway inflammation and iNKT-cell-dependent airway hyperreactivity in opposing directions. Mucosal Immunol (2009) 1.53
B7-H1-induced apoptosis as a mechanism of immune privilege of corneal allografts. J Immunol (2006) 1.52
Role of the programmed Death-1 pathway in the suppressive activity of alternatively activated macrophages in experimental cysticercosis. Int J Parasitol (2005) 1.47
Regulation of T cell activation and tolerance by PDL2. Proc Natl Acad Sci U S A (2006) 1.46
Genetic susceptibility to type 1 diabetes. Curr Opin Immunol (2005) 1.38
T regulatory cells in allergy: novel concepts in the pathogenesis, prevention, and treatment of allergic diseases. J Allergy Clin Immunol (2005) 1.38
PD-L1 and PD-L2 have distinct roles in regulating host immunity to cutaneous leishmaniasis. Eur J Immunol (2006) 1.38
Chemopreventive agents induce programmed death-1-ligand 1 (PD-L1) surface expression in breast cancer cells and promote PD-L1-mediated T cell apoptosis. Mol Immunol (2007) 1.35
B7-DC induced by IL-13 works as a feedback regulator in the effector phase of allergic asthma. Biochem Biophys Res Commun (2007) 1.29
Dendritic cell programming by cytomegalovirus stunts naive T cell responses via the PD-L1/PD-1 pathway. J Immunol (2008) 1.27
PD-1 ligands expressed on myeloid-derived APC in the CNS regulate T-cell responses in EAE. Eur J Immunol (2008) 1.27
Retracted Naturally occurring human IgM antibody that binds B7-DC and potentiates T cell stimulation by dendritic cells. J Immunol (2003) 1.21
Allergy and asthma. J Allergy Clin Immunol (2005) 1.20
Programmed death 1 ligand (PD-L) 1 and PD-L2 limit autoimmune kidney disease: distinct roles. J Immunol (2007) 1.17
An anti-inflammatory role for plasmacytoid dendritic cells in allergic airway inflammation. J Immunol (2009) 1.17
Asthma phenotypes. Curr Opin Pulm Med (2007) 1.10
CD4+ PD-1+ T cells accumulate as unique anergic cells in rheumatoid arthritis synovial fluid. J Rheumatol (2003) 1.09
Retracted Blockade of allergic airway inflammation following systemic treatment with a B7-dendritic cell (PD-L2) cross-linking human antibody. J Immunol (2004) 1.09
Turning on the off switch: regulation of anti-viral T cell responses in the liver by the PD-1/PD-L1 pathway. J Hepatol (2006) 1.06
Paradoxical role of programmed death-1 ligand 2 in Th2 immune responses in vitro and in a mouse asthma model in vivo. Eur J Immunol (2004) 0.97
Increased salivary gland tissue expression of Fas, Fas ligand, cytotoxic T lymphocyte-associated antigen 4, and programmed cell death 1 in primary Sjögren's syndrome. Arthritis Rheum (2003) 0.96
Dendritic cells in allergic airway inflammation. Can J Physiol Pharmacol (2007) 0.92
Allergic airways disease develops after an increase in allergen capture and processing in the airway mucosa. J Immunol (2007) 0.91
Involvement of programmed death-ligand 2 (PD-L2) in the development of experimental allergic conjunctivitis in mice. Br J Ophthalmol (2006) 0.90
Fms-like tyrosine kinase 3 ligand increases a lung DC subset with regulatory properties in allergic airway inflammation. J Allergy Clin Immunol (2009) 0.90
Keratinocyte-associated B7-H1 directly regulates cutaneous effector CD8+ T cell responses. J Immunol (2010) 0.87
Programmed Death-1 antibody blocks therapeutic effects of T-regulatory cells in cockroach antigen-induced allergic asthma. Am J Respir Cell Mol Biol (2009) 0.84
Enhanced expression of programmed death-1 (PD-1)/PD-L1 in salivary glands of patients with Sjögren's syndrome. J Rheumatol (2005) 0.82
Identification of Tapr (an airway hyperreactivity regulatory locus) and the linked Tim gene family. Nat Immunol (2001) 4.05
Seroconversion to human immunodeficiency virus in prison inmates. Am J Public Health (1990) 2.07
PD-L1 and PD-L2 modulate airway inflammation and iNKT-cell-dependent airway hyperreactivity in opposing directions. Mucosal Immunol (2009) 1.53
CD8α⁺β⁻ and CD8α⁺β⁺ plasmacytoid dendritic cells induce Foxp3⁺ regulatory T cells and prevent the induction of airway hyper-reactivity. Mucosal Immunol (2012) 1.52
A multicenter analysis of the first experience with FK506 for induction and rescue therapy after pancreas transplantation. Transplantation (1996) 1.14
The HSC73 molecular chaperone: involvement in MHC class II antigen presentation. J Immunol (1999) 1.03
Tract-based spatial statistics of diffusion tensor imaging in adults with dyslexia. AJNR Am J Neuroradiol (2008) 1.02
Resiquimod, a new immune response modifier from the family of imidazoquinolinamines, inhibits allergen-induced Th2 responses, airway inflammation and airway hyper-reactivity in mice. Clin Exp Allergy (2004) 0.95
Solid organ transplantation in the HIV-infected patient. Am J Transplant (2009) 0.94
Hepatic progenitor cells from adult human livers for cell transplantation. Gut (2008) 0.93
Beneficial and detrimental effects of RBC-adsorbed antilymphocyte globulin and prednisone on purified canine islet autograft and allograft function. Transplantation (1991) 0.92
Sequence characterization and expression patterns of defensin and lysozyme encoding genes from the gut of the reduviid bug Triatoma brasiliensis. Insect Biochem Mol Biol (2006) 0.90
Health-related fitness and quality of life following steroid withdrawal in renal transplant recipients. Kidney Int (2003) 0.89
Living related donor liver transplantation: the UCSF experience. Transplant Proc (1996) 0.88
Treatment-dependent loss of polyfunctional CD8+ T-cell responses in HIV-infected kidney transplant recipients is associated with herpesvirus reactivation. Am J Transplant (2009) 0.88
Pharmacokinetics of 6-thiouric acid and 6-mercaptopurine in renal allograft recipients after oral administration of azathioprine. Eur J Clin Pharmacol (1989) 0.87
Functional and phenotypical characterization of activated T cells from intra-articular sites in inflammatory joint diseases. Possible modulation of the CD3 antigen. Scand J Immunol (1987) 0.87
The risk and opportunity of homeostatic repopulation. Am J Transplant (2011) 0.87
Isolation and hepatocyte differentiation of mesenchymal stem cells from porcine bone marrow--"surgical waste" as a novel MSC source. Transplant Proc (2013) 0.85
De novo use of sirolimus in immunosuppression regimens in kidney and kidney-pancreas transplantation at the University of California, San Francisco. Transplant Proc (2003) 0.84
Peginterferon and ribavirin for treatment of recurrent hepatitis C disease in HCV-HIV coinfected liver transplant recipients. Am J Transplant (2014) 0.84
Alterations in skeletal muscle structure are minimized with steroid withdrawal after renal transplantation. Transplantation (2003) 0.82
Human albumin preserves islet mass and function better than whole serum during pretransplantation islet culture. Transplant Proc (2008) 0.82
Decreased mortality from technical failure improves results in pediatric liver transplantation. Arch Surg (1996) 0.80
Role of plasmacytoid dendritic cell subsets in allergic asthma. Allergy (2013) 0.80
Pediatric liver transplantation across ABO blood group barriers. Transplant Proc (1989) 0.80
Pretransplant islet culture: a comparison of four serum-free media using a murine model of islet transplantation. Transplant Proc (2005) 0.80
T-cell co-stimulatory molecules: their role in allergic immune reactions. Eur Respir J (2007) 0.80
Experience with steroid-free maintenance immunosuppression in simultaneous pancreas-kidney transplantation. Transplant Proc (2004) 0.79
Evidence for primary genetic determination of heart rate regulation: chromosomal mapping of a genetic locus in the rat. Circulation (1997) 0.79
Role of the cardiac renin-angiotensin system in human heart failure. Adv Exp Med Biol (1995) 0.78
The Y chromosome. Epistatic and ecogenetic interactions in genetic hypertension. Hypertension (1996) 0.78
[The influence of extracellular calcium on volume, enzyme and calcium secretion in the isolated perfused canine pancreas (author's transl)]. Res Exp Med (Berl) (1977) 0.78
Permanent acceptance of islet allografts in mice is not associated with immunologic tolerance. Transplant Proc (1987) 0.78
Clinical islet transplantation experience of the University of California Islet Transplant Consortium. Surgery (1995) 0.77
Intraoperative fluid management of living donor versus cadaveric liver transplant recipients. Transplant Proc (2004) 0.77
Calcium secretion in the isolated perfused canine pancreas. Res Exp Med (Berl) (1979) 0.75
Strategies for tolerance induction: potential applications in living donor liver transplantation. Transplant Proc (1996) 0.75
Vitamin D in early life: good or bad for food allergies? Allergy (2013) 0.75
Re-evaluation of donor factors affecting islet isolation from human pancreas using a two-step digestion method. Transplant Proc (1997) 0.75
Cardiorespiratory fitness in pancreas-kidney transplant recipients. Transplant Proc (1998) 0.75
Plasma amino acid clearance predicts hepatic recovery after normothermic anoxia and cold preservation. Transplant Proc (1987) 0.75
[Reactions with imide acid esters. VI. Transformation of imide acid esters with beta-amino crotonic acid ester]. Justus Liebigs Ann Chem (1966) 0.75
Use of triple therapy and percutaneous needle biopsy to minimize graft failure following liver transplantation. Transplant Proc (1987) 0.75
Comparative in vitro immunogenicity of cultured murine islets and hepatocytes. Transplant Proc (1989) 0.75
Monitoring bruxism. Med Biol Eng Comput (1983) 0.75
Pancreatic islets generate allospecific cytolytic T lymphocytes in a mixed lymphocyte-islet culture. Curr Surg (1988) 0.75